Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

European Journal of Cancer

Volumn 31, Issue 12, 1995, Pages 1969-1975

  Scholl, S M ^a   Pierga, J Y ^a   Asselain, B ^a   Beuzeboc, P ^a   Dorval, T ^a   Garcia Giralt, E ^a   Jouve, M ^a   Palangie T ^a   Remvikos, Y ^a   Durand, J C ^a   Fourquet, A ^a   Pouillart, P ^a  

^a INSTITUT CURIE   (France)

Author keywords

breast cancer; breast preservation; chemosensitivity; drug resistance; neoadjuvant chemotherapy; prognosis; S phase

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CLINICAL TRIAL; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029584199     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00454-8     Document Type: Article

References (18)

1. Clinical significance of P-glycoprotein in multidrug resistance malignancies
2. P-glycoprotein expression in treated and untreated human breast cancer
3. HER-2/neu in node negative breast cancer. Prognostic significance of overexpression influenced by the presence of in-situ carcinoma
4. Gusterson BA
5. C erbB2 expression and response to adjuvant therapy in women with node positive early breast cancer
6. Antineoplastic drug resistance and breast cancer
7. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomized trial: S6
8. DNA flow cytometry applied to fine needle samplings of human breast cancer
9. Evaluation of survival data and two new rank order statistics arising in its consideration
10. Non parametric estimation from incomplete observations
11. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy
12. Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy
13. Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast
14. The use of flow cytometry for the prognosis of stage II adjuvant-treated breast cancer patients
15. DNA ploidy and percent ofS-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials
16. Prognosis and treatment decisions in patients with breast cancer without axillary node involvement
17. Age as prognostic factor in premenopausal breast carcinoma
18. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients